A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+Obinutuzumab (GA101) in Participants With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Bendamustine
Related studies linked through entity extraction aliases.
A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)
- Status
- COMPLETED
- Phase
- PHASE4
Study to Evaluate the Combination of Bendamustine, Bortezomib and Dexamethasone (BBD) in the First-Line Treatment of Patients With Multiple Myeloma Who Are Not Candidates for High Dose Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Peripheral Blood Stem Cell (PBSC) Mobilization in Patients With Relapsed Lymphoma Treated With Bendamustine
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Bendamustine Plus Rituximab Versus CHOP Plus Rituximab
- Status
- COMPLETED
- Phase
- PHASE3
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
- Status
- COMPLETED
- Phase
- PHASE2
Bendamustine in Patients With Refractory or Relapsed T-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Bendamustine Combined With Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Conditioning Regimen of Bendamustine and Melphalan Followed by Transplant in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bendamustine, Mitoxantrone, and Rituximab (BMR) for Patients With Untreated High Risk Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)
- Status
- TERMINATED
- Phase
- PHASE2
Bendamustine Hydrochloride in Combination With Rituximab in Patients With Relapsed Refractory Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Study Bendamustine Concurrent Whole Brain Radiation Brain Metastases From Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study
- Status
- COMPLETED
- Phase
- PHASE3
Pharmacokinetics of Bendamustine Hydrochloride in Patients With Relapsed or Refractory Malignancy
- Status
- COMPLETED
- Phase
- PHASE1
Bendamustine and Radiation Therapy in Treating Patients With Brain Metastases Caused by Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1